Log In
Print this Print this

NeuVax, nelipepimut-S (E75)

  Manage Alerts
Collapse Summary General Information
Company Galena Biopharma Inc.
DescriptionVaccine consisting of an immunogenic peptide derived from epidermal growth factor receptor 2 (EGFR2; HER2; ErbB2; neu) and sargramostim
Molecular Target
Mechanism of ActionVaccine; Immunotherapy
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I
Standard IndicationGastric cancer
Indication DetailsTreat gastric cancer
Regulatory Designation
PartnerDr. Reddy's Laboratories Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today